Heart Disease Clinical Trials in Denver

Showing 321-340 of 365 trials

Denver Health Cardiovascular Disease (CVD) Prevention Program

NCT00829491

The objective of the Denver Health CVD Prevention Program is to assess the effectiveness of developing an enhanced cardiovascular disease prevention program in a community health care setting.

Cardiovascular Disease

Denver Health and Hospital Authority340 participantsStarted Mar 2007

Denver, Colorado, United States

TERMINATEDPhase 1< 1 mile

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

NCT00291551

This is a limited safety and feasibility study to evaluate the PVSS Introducer and Paracor Ventricular Support System when used to treat patients with heart failure. The implant, which is loaded onto the delivery system, is placed over the epicardial surface of the right and left ventricles. No formal hypothesis testing will be performed; descriptive statistics will be used to summarize patient outcomes. The results of the study will be used to guide the design and sample size estimation of future studies.

Heart Failure, Congestive

Paracor Medical, Inc39 participantsStarted Jan 2005

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +9 more locations

Denver Health Cardiovascular Disease (CVD) Prevention Program

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Heart Disease Trials in Other Cities

Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Attain Success Clinical Trial

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Other Conditions in Denver